Home›Stock Screener›Shelter Pharma

Shelter Pharma Share Price Today | Stock Price & Shelter Pharma Share Screener

SHELTER Pharmaceuticals & Biotechnology

Track the current Shelter Pharma share price and stock price live with TickJournal's free stock screener. Track Shelter Pharma market worth to gauge the company's total market size. Use the Shelter Pharma stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Shelter Pharma opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Shelter Pharma Market Cap ₹75.21 Cr.
SHELTER P/E Ratio (TTM) -
Shelter Pharma P/B Ratio 1.07
EPS (TTM) ₹6.57
Dividend Yield 0.76%
Debt to Equity 0.02
SHELTER 52 Week High -
Shelter Pharma 52 Week Low -
Operating Margin -
Profit Margin -
SHELTER Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹84.00
Total Equity ₹77.00

Shelter Pharma Share Price Chart

Track the current stock price of Shelter Pharma with an interactive chart. Analyse SHELTER share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Shelter Pharma stock quote in one place.

Shelter Pharma Company Profile - Fundamental Screener

Screen Shelter Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SHELTER shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE013V01011.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE013V01011

Shelter Pharma Balance Sheet Screener

Screen SHELTER balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹84, up from ₹48 in 2025.

Latest statistics put total assets at ₹84 and shareholder funds at ₹77, with a leverage ratio of 0.02.

Item 2026 2025 2024 2023 2022 2021 2020

Assets

Total Assets 84 48 38 21 13 10 11
Current Assets 0 0 0 0 0 0 0
Fixed Assets 7 6 4 2 2 2 2

Liabilities

Total Liabilities 0 0 0 0 0 0 0
Current Liabilities 1 1 1 1 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 77 43 36 15 9 7 7
Share Capital 17 12 12 8 1 1 1
Reserves & Surplus 56 31 24 7 8 7 7

Shelter Pharma Income Statement Screener - Profit & Revenue Analysis

Screen Shelter Pharma income statement and profit fundamentals. Analyze SHELTER quarterly results. Shelter Pharma reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹73 and net profit of ₹9.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March

Revenue and Expenses

Revenue 0 73 51 40 36 30 23 30
Expenses 0 60 41 32 28 27 22 30

Operating Costs and Margins

EBITDA 0 13 10 9 8 3 0 0
Operating Profit % 0.00% 17.00% 20.00% 21.00% 22.00% 10.00% 1.00% 1.00%
Depreciation 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 0 12 10 8 7 3 0 0
Tax 0 3 2 2 2 1 0 0
Net Profit 0 9 7 6 5 2 0 0
EPS 0.00 6.57 6.26 5.36 6.72 42.54 0.88 1.77

Shelter Pharma Cash Flow Screener - Liquidity Fundamentals

Screen SHELTER cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹13, and net cash flow was an outflow of ₹2.

Over the same period, investing activities used ₹15 and financing activities provided ₹25.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2017-March

Cash from Operations and Investing

Operating Activities -13 5 -2 0 1 0 0 0
Investing Activities -15 -7 -4 0 -1 0 0 0

Financing and Net Cash

Financing Activities 25 0 11 0 0 1 0 0
Net Cash Flow -2 -2 5 0 0 0 0 0

Shelter Pharma Shareholding Pattern Screener

See Shelter Pharma shareholding pattern with promoter, FII, and DII holdings. Check Shelter Pharma promoter holding and ownership changes for SHELTER on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Oct, promoters held 46.11%, foreign institutions 0.00%, domestic institutions 0.00% and the public 47.51%, spread across 1,015 shareholders.

The shareholder count was 1,015 in 2026-Oct, compared with 1,048 in 2026-Sept.

Item 2026-Oct 2026-Sept 2026-May 2026-Mar 2025-Nov 2025-Oct 2025-Sept 2025-Aug

Promoter Holding

Promoter Holding 46.11% 44.60% 44.38% 44.38% 47.19% 46.98% 52.32% 52.32%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 47.51% 51.82% 51.46% 51.46% 49.32% 48.66% 42.82% 42.69%
Other Holding 6.39% 3.59% 4.16% 4.16% 3.49% 4.36% 4.86% 4.99%
Shareholder Count 1,015 1,048 1,076 1,071 1,093 1,094 1,094 1,109

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Shelter Pharma. Shelter Pharma dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Shelter Pharma.

Shelter Pharma Stock Index Membership - Nifty & Sensex

See which indices include Shelter Pharma stock. Check SHELTER index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Shelter Pharma is not part of any tracked indices.
Only major market indices are tracked in our system.

Shelter Pharma Market Events Screener - Corporate Actions

Get Shelter Pharma corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Shelter Pharma stock events that may affect SHELTER share price, along with derivatives, futures and options activity and sector gainers.

11 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 7, 2026, with a record date of November 7, 2026.

It is followed by Annual General Meeting dated September 29, 2026 and Quarterly Result Announcement dated May 28, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-07 2026-11-07 Quarterly Result Announcement NA 0.51%
2026-09-29 2026-09-29 Annual General Meeting NA 18.41%
2026-05-28 2026-05-28 Quarterly Result Announcement NA -3.23%
2025-11-10 2025-11-10 Quarterly Result Announcement NA 0.87%
2025-09-30 2025-09-30 Annual General Meeting NA -2.22%
2025-09-23 2025-09-23 Dividend ₹ 0.35 /share -3.84%
2025-07-23 2025-07-23 Extraordinary General Meeting NA 11.04%
2025-05-29 2025-05-29 Quarterly Result Announcement NA 3.95%
2024-10-30 2024-10-30 Quarterly Result Announcement NA 0.58%
2024-09-30 2024-09-30 Annual General Meeting NA 1.13%
2024-09-23 2024-09-23 Dividend ₹ 0.33 /share 2.64%

Shelter Pharma Competitors Screener - Peer Stocks Comparison

Screen SHELTER competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 448,676 40.80 61,674 12.69% 11,565 60.46
Divis Laboratories 295,997 87.70 11,067 13.95% 2,568 68.76
Torrent Pharmaceuticals 177,586 85.00 13,886 20.34% 2,138 47.23
Laurus Labs 126,325 89.90 6,868 22.01% 890 57.04
Zydus Life Science 120,119 27.60 27,658 17.64% 5,026 55.91
Dr Reddys Laboratories 115,854 41.80 35,059 3.90% 4,158 71.26
Cipla 112,131 39.50 29,045 2.24% 3,870 53.06
Mankind Pharma 107,805 47.90 14,636 14.85% 1,938 61.37
Aurobindo Pharma 103,229 25.80 34,145 5.56% 3,503 60.39
Lupin 89,172 17.30 29,039 26.75% 5,356 39.39

Shelter Pharma Company Announcements - News & Reports Screener

Screen SHELTER latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 9, 2026.

The next most recent announcements are dated November 9, 2026 and November 9, 2026.

Date Update Actions
2026-11-09 Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-11-09 Submission Of The Un-Audited Standalone Financial Results For The Half Year Ended September 30 2026 -
2026-11-09 Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of The Un-Audited Standalone Financial Results For The Half Year Ended September 30 2026 -
2026-11-04 Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Day 07Th November 2026 -
2026-10-29 Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order -
2026-10-16 Announcement under Regulation 30 (LODR)-Allotment -
2026-10-16 Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday October 16 2026 For Conversion Of Warrants Into Equity Shares -
2026-10-10 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-29 Announcement under Regulation 30 (LODR)-Change in Management -
2026-09-29 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-29 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-25 Closure of Trading Window -
2026-09-23 Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Positive DoctorS Review And Feedback On Company Products. -
2026-09-22 Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order -
2026-09-18 Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 -Participation In Vishwa Ayurveda Parishad Exhibition -
2026-09-07 Newspaper Advertisement - Notice To The Members Of The Company Regarding 19Th Annual General Meeting To Be Held At The Registered Office Of The Company On Tuesday 29Th September 2026 -
2026-09-04 Notice Of AGM - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-09-04 Reg. 34 (1) Annual Report. -
2026-09-01 Intimation Of The Cut-Off Date For The AGM Of The Company "Shelter Pharma Limited" -
2026-09-01 Announcement under Regulation 30 (LODR)-Change in Management -

Frequently Asked Questions

How is the company valued right now?

The P/B ratio is 1.07. Market capitalisation stands at ₹75.21 Cr and the dividend yield is 0.76%. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on November 19, 2026. This page covers 7 balance sheet periods, 8 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.